Back to Agenda
Plenary Session: Asia at the Forefront of the Healthcare Evolution
Session Chair(s)
Finny Liu, MSc, RPh
APAC Regional Regulatory Policy Lead
Roche, Singapore
James Leong, PhD, MPharm
Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore
Healthcare in Asia has been rapidly re-invented due to COVID-19 pandemic and also the evolutions of innovative technologies, regulatory agility and the empowerment of patients in healthcare decision-making.
In this session, our keynote speakers will share the landscape of healthcare, showcase recent trends in innovation launched or therapeutics focused on disease prevalent in this region, and the efforts from the regulators to enable the adoption of new technologies and treatments, aims to showcase recent trends in innovation launched in Asia or therapeutics focused on disease prevalent in this region. In the plenary panel discussion, relevant stakeholders in healthcare will share their perspectives and their strategic insights on the healthcare ecosystem in Asia.
Speaker(s)
Healthcare Perspective
Michael Ho
National Health Innovation Centre Singapore (NHIC), Singapore
Head - Innovation and Strategy
Access Perspective
Krishna Reddy
Access Health International, India
Regional Director - Southeast Asia
Regulatory Perspective
Su Lin Dorothy Toh, PhD
Health Sciences Authority, Singapore
Asst Group Director - Health Products Regulation Group
Have an account?